This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Obama Stays Home to Finish Health Fight

WASHINGTON D.C. ( TheStreet) -- President Obama is again delaying his trip to the Pacific as the contentious health care bill makes its way towards a vote this Sunday.

President Obama was scheduled to visit Guam and other Pacific nations, however, given the magnitude of the health care battle, decided it would be better to circle around the Capitol Dome for a few more days.

Thursday has been a numbers-game day in the home stretch of President Obama's effort to enact health reform legislation.

U.S. House Majority Leader Steny Hoyer said a final vote on the legislation could come by Sunday as Democrats attempt to line up the final votes.

Hoyer was among Democrats leading the charge with the just-released numbers from the Congressional Budget Office (CBO) showing that health care reform would not just save $138 billion in its first ten years, but more than $1.2 trillion over the subsequent decade -- though the longer-term forecasts are viewed by many critics in Washington as having a healthy margin of error.

Republicans were quick to jump on health care reform price tag of $940 billion over the first 10 years, and the same CBO's data that the U.S. government has already racked up a $655 billion deficit through the first five months of 2010 -- which includes economic stimulus spending.

Leading Republicans linked the spending figure to the current weak state of the U.S. economy, and aimed to stoke fears that the government would be setting up future generations for a massive debt load.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,672.60 -141.38 -0.79%
S&P 500 2,051.82 -11.33 -0.55%
NASDAQ 4,757.8790 +7.4820 0.16%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs